Topics

Latest "Damon Runyon Cancer Research Foundation" News Stories

21:38 EST 27th February 2020 | BioPortfolio

Here are the most relevant search results for "Damon Runyon Cancer Research Foundation" found in our extensive news archives from over 250 global news sources.

More Information about Damon Runyon Cancer Research Foundation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Damon Runyon Cancer Research Foundation for you to read. Along with our medical data and news we also list Damon Runyon Cancer Research Foundation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Damon Runyon Cancer Research Foundation Companies for you to search.

Showing "Damon Runyon Cancer Research Foundation" News Articles 1–25 of 40,000+

Thursday 27th February 2020

MIDDLE EAST AND AFRICA SMART METER DATA MANAGEMENT MARKET 20192027 [Published by Triton Market Research] Prices from USD $1275

MARKET OUTLOOKTriton Market Research has estimated the growth of the smart meter data management market in the Middle East and Africa at a CAGR of 16.60% during the forecasted period 20192027.The UAE, South Africa, Saudi Arabia, Turkey, and the Rest of the Middle East and Africa constitute the market for smart meter data management in the Middle East and Africa region.Subsidy reform policies and m...


Global Orthopedic Implants Market 2020-2024 | Evolving Opportunities With B. Braun Melsungen AG and CONMED Corp. | Technavio

The global orthopedic implants market is poised to grow by USD 10.09 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period. Request free sample pages This press release features multimedia. View the full release here:

Snack Bars Market in the US 2020-2024 | Evolving Opportunities with Abbott Laboratories and Clif Bar & Co. | Technavio

The snack bars market in the US is poised to grow by USD 806.08 million during 2020-2024, progressing at a CAGR of over 2% during the forecast period. Request free sample pages This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20


Global Convection Microwave Market Research 20152019 and Future Forecast 20202025 [Published by 99Strategy] Prices from USD $2805

SummaryThe report forecast global Convection Microwave market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 20202025.The report offers detailed coverage of Convection Microwave industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Convection Micr...

A Nature paper identifies a distinct mutational signature in colorectal cancer linked to bacterial infection. This signature may be directly traced to past exposure to a specific strain of Escherichia coli. https://go.nature.com/2ThsGpU pic.twitter.com/

A Nature paper identifies a distinct mutational signature in colorectal cancer linked to bacterial infection. This signature may be directly traced to past exposure to a specific strain of Escherichia coli. https://go.nature.com/2ThsGpU  pic.twitter.com/1Gy2VOmO29

5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming

Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli

Working Scientist podcast: How to get media coverage for your research

Celprogen Awarded ISO 9001-2015 Certification

Celprogen Inc., a global leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have been awarded the ISO 9001-2015 Certification; the internationally recognized standards to ensures that our products and services meet the needs of our global clients through an effective quality management system. Celprogen has developed and imple...

Global sterilization Container System Market Research 20152019 and Future Forecast 20202025 [Published by 99Strategy] Prices from USD $2805

SummaryThe report forecast global sterilization Container System market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 20202025.The report offers detailed coverage of sterilization Container System industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the lea...

Boehringer Ingelheim Enters Collaborates with Trutino Biosciences to Grow its Cancer Immunology Portfolio with Novel Cytokine Platform

INGELHEIM, Germany & SAN DIEGO, California–(BUSINESS WIRE)–Boehringer Ingelheim and Trutino Biosciences today announced they have entered into a research collaboration and worldwide licensing agreement based on Trutino’s innovative On-Demand-Cytokine (ODC) platform. Under the terms of strategic alliance, Boehringer Ingelheim gains access to Trutino’s ODC platform technology for...

Christina Renna Foundation donates $38k to study sarcoma

On January 25th, the Christina Renna Foundation (CRF) donated $38,000 to Cold Spring Harbor Laboratory (CSHL) at its 13th annual Angel’s Wish Gala. The funds will go to continued research into rhabdomyosarcoma (RMS), a rare and often fatal form of pediatric cancer. In total, CRF has donated $330,000 to research at CSHL. “CRF is extremely... The post

Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases

Broad collaboration for gene regulation therapies in neurology, initially focused on development of ST-501 for tauopathies including Alzheimer’s disease, ST-502 for synucleinopathies including Parkinson’s disease, and a neuromuscular target, with exclusive rights for nine additional undisclosed neurological targets Biogen will pay Sangamo $350 million upfront, including a license fee and a...

Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results

2020 data milestones remain on track for proprietary programs Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, today announced results for the fourth quarter and year ended December 31, 2019, in addition to providing an update on the company’s recent activities. “Our...

Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products. The complaint was filed against BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc. and Complete Genomics Inc. in the United States District Court for the Northern District of California alleging infringement of three pate...

Dicerna™ Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

— Company Achieves Multiple Clinical and Corporate Development Milestones in 2019, Advancing Core Pipeline Candidates; Expanding and Progressing Existing Collaborative Programs; and Establishing New, High-Value Collaborations With Roche and Novo Nordisk A/S — — Anticipated 2020 Milestones Include: First Nedosiran Multi-dose Data From PHYOX™3 Trial; RG6346 Phase 1 Proof-of-Concept Data; ...

Spectrum Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Pipeline Update

BLA for ROLONTIS® (eflapegrastim) accepted for FDA review - PDUFA date on October 24, 2020 Data from poziotinib Cohort 1 of ZENITH20 accepted for podium presentation on March 18 at 11th Annual Congress on Pulmonary and Respiratory Medicine in Amsterdam Spectrum plans to hold a conference call following the data presentation to review the data and strategy of the program Spectrum Pharmaceuti...

Deciding If Older Women Need to Keep Having Routine Mammograms

Observational analysis of Medicare data suggests continuing annual screening mammography after age 75 does not lower risk for death from breast cancer.

What Oncologists Need to Know About USP <800> and the Recent Clarification

Patients with cancer across the country rely on community oncology practices to provide them with high-quality, coordinated cancer care. 

Global Sterilization Monitoring Market 2020-2024 | Evolving Opportunities With 3M Co. and Cantel Medical Corp. | Technavio

Technavio has been monitoring the global sterilization monitoring market since 2017 and the market is poised to grow by USD 259.99 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period. Request free sample pages This press release features multimedia. View

Medidata Institute and Project ALS Launch Partnership to Accelerate New Treatment Strategies

Medidata to apply proprietary artificial intelligence tools to aid the fight against ALS New initiative is part of Medidata’s ongoing commitment to rare diseases Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions supporting the entire clinical trial process, announced the launch of a research partnership between the

Segal Trials Screens its First Patient in a study of Psilocybin for Major Depressive Disorder

Over the years, Segal Trials has grown into one of the premier, privately held clinical trial sites in the U.S., with six sites located in South Florida and Charleston, South Carolina focusing on mental health and women's health; and has been awarded groundbreaking studies such as the use of Psilocybin as a treatment for MDD in the study PSIL201 (ClinicalTrials.gov Identifier: NCT03866174). LA...

Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma

RMAT designation follows positive proof-of-concept data from two independent Phase I/II clinical studies conducted by Baylor College of Medicine and University of North Carolina Lineberger Comprehensive Cancer Center for the autologous T cell therapy Designation includes early interactions with the FDA to facilitate development and discuss potential for expedited review ...

Phunware Adds Top US Cancer Center as Mobile Digital Front Door Customer

Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, today announced that it has added one of the top rated

LivaNova, Verily collaborate on new approach for RECOVER trial

US-based medical technology firm LivaNova has entered into research collaboration with Verily, an Alphabet company, to capture measures of depression within its RECOVER clinical study. The RECOVER trial The post LivaNova, Verily collaborate on new approach for RECOVER trial appeared first on NS Medical Devices.


Quick Search

News Quicklinks